Neuronetics, Inc.
STIM
$1.24
-$0.04-3.13%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 34.45M | 41.78M | 37.30M | 38.11M | 31.98M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 34.45M | 41.78M | 37.30M | 38.11M | 31.98M |
| Cost of Revenue | 18.30M | 19.67M | 20.19M | 20.35M | 16.24M |
| Gross Profit | 16.15M | 22.10M | 17.11M | 17.76M | 15.74M |
| SG&A Expenses | 23.79M | 25.08M | 22.93M | 24.02M | 25.14M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 43.45M | 46.42M | 44.62M | 46.17M | 42.99M |
| Operating Income | -9.00M | -4.64M | -7.32M | -8.06M | -11.01M |
| Income Before Tax | -10.78M | -7.21M | -9.40M | -9.84M | -12.69M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -10.78M | -7.21M | -9.40M | -9.84M | -12.69M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -10.00K | 48.00K | 356.00K | -281.00K | 14.00K |
| Net Income | -10.79M | -7.16M | -9.05M | -10.12M | -12.68M |
| EBIT | -9.00M | -4.64M | -7.32M | -8.06M | -11.01M |
| EBITDA | -8.27M | -3.94M | -6.44M | -7.14M | -10.12M |
| EPS Basic | -0.16 | -0.10 | -0.13 | -0.15 | -0.21 |
| Normalized Basic EPS | -0.09 | -0.06 | -0.08 | -0.10 | -0.13 |
| EPS Diluted | -0.16 | -0.10 | -0.13 | -0.15 | -0.21 |
| Normalized Diluted EPS | -0.09 | -0.06 | -0.08 | -0.10 | -0.13 |
| Average Basic Shares Outstanding | 69.59M | 68.76M | 67.31M | 66.18M | 61.47M |
| Average Diluted Shares Outstanding | 69.59M | 68.76M | 67.31M | 66.18M | 61.47M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |